Development of Czech National Stroke Guidelines
Jazyk angličtina Země Austrálie Médium print
Typ dokumentu časopisecké články
PubMed
31283569
DOI
10.1097/xeb.0000000000000190
PII: 01787381-201906001-00004
Knihovny.cz E-zdroje
- MeSH
- antikoagulancia aplikace a dávkování MeSH
- cévní mozková příhoda farmakoterapie prevence a kontrola MeSH
- fibrilace síní farmakoterapie MeSH
- ischemie mozku prevence a kontrola MeSH
- lidé MeSH
- medicína založená na důkazech MeSH
- směrnice jako téma MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika MeSH
- Názvy látek
- antikoagulancia MeSH
Despite a significant transformation of ischaemic stroke management, it remains one of the leading causes of death, disability, functional impairment and cognitive deficits. With the advent of intravenous thrombolysis and mechanical thrombectomy, stroke is not an untreatable disease, mostly occurring in older people, any more. The most common cause of cardioembolic strokes is atrial fibrillation or flutter and atrial fibrillation is the most prevalent arrhythmia.The aim of this short communication is to describe the methodology of the Czech stroke guidelines development.High-quality 2017 Australian Stroke Foundation stroke guideline was considered for adaptation and a new guideline was developed and disseminated.
Department of Neurology Faculty of Medicine University Hospital Brno Masaryk University Brno
Department of Neurology Faculty of Medicine University Hospital Olomouc Palacky University Olomouc
Department of Neurology Faculty of Medicine University Hospital Ostrava Ostrava University Ostrava
Department of Neurology Regional Hospital Chomutov Chomutov
Department of Paediatrics T Bata Regional Hospital Zlin Czech Republic
Motol University Hospital Department of Neurology 2nd Faculty of Medicine Charles University Prague
Citace poskytuje Crossref.org